Annual Report

Overview

The report presents GSK India's FY 2021-22 strategy around Innovation, Performance and Trust, alongside its purpose to unite science, technology and talent. It reports consolidated revenue from operations of INR 3278,02.92 lakhs and highlights the business's vaccine and dermatology leadership. Sustainability disclosures include NGRBC-aligned BRSR reporting, CSR programmes involving 32 million albendazole tablets, and environmental initiatives such as solar installation and water reduction. The BRSR also states that current-year non-financial data was not independently audited.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2021-2022
Period: 1 April 2021 – 31 March 2022
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services